Monday, February 8, 2010
"The source for European pharmaceutical biotechnology news..."
Sponsors
Platinum Sponsors
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Marie Shields
Editor NGP Europe
Editor NGP Europe
Tough competition
The battle between generics and branded products has been going on for a long time: the claims and counter claims over Aspirin, for example, have been in process since the early 20th century.05 Aug 2009
Focus Areas
Cover Stories
Branding pharma
The pharmaceutical industry has turned up at branding’s door like the 40-year old virgin: late but eager. The question is, does it have...
Sales and marketing strategies
Weak pipelines, patent expiries, the rise of generics and a lack of blockbusters… is it any surprise that sales and marketing strategies are...
Virgin birth
The king of branding, Sir Richard Branson, is to launch his most controversial business yet.
Roundtables
Vendor Perspectives
-
Growing revenue
By Steven Vantongelen, Managing Partner, Sales Performance International – Southern Europe: Never before have sales and marketing organisations struggled so mightily to...Read more -
The data and knowledge management challe...
By Paul Denny-Gouldson, Scott Weiss and Glyn Williams, ID Business SolutionsRead more
Industry Analysts
-
The challenging world of compliance
Life sciences companies face an increasing level of compliance challenges and pressures as the complex web of regulations continues to multiply. By Kevin O’Leary, QUMASRead more -
Doctor-patient encounter communication
For the last five years, Glenn MacEachern has lead the commercial development and launch of Schwarz Pharma’s orally disintegrating tablet franchise of brands, including...Read more -
Know more, sell more
Better information is the key to success in an increasingly difficult sales environment, say Dorothy Knightley and David Owen, TNS Healthcare.Read more -
Managing maintenance (and much more)
Pharmaceutical and biotech companies are under unprecedented pressure to manage their costs more effectively. By Jeff Weinert, General Manager, Scientific Asset Services,...Read more -
The L-Factor: "We’ve got the critical mass”
Franz Humer, a lawyer by training, is CEO of F. Hoffmann-La Roche Ltd – a company whose strategy is to use innovative scientific breakthroughs to shape the future of medicine.Read more
Executive Interviews
Executive Insight: LIMS
Talking with Dave Champagne, Vice President and General Manager, and Kim Shah, Director of Marketing and Business Development, for Informatics at Thermo Fisher Scientific.
Read more
“All business organisations will benefit”
Talking with Sparta Systems about the benefits of implementing its TrackWise® quality and compliance management software.
Read more
How today’s next generation ELNs can help drive...
A question and answer session on how Electronic Laboratory Notebooks (ELNs) have evolved over recent years. With ID Business Solutions
Read more
NGP Europe Summit: Drug Discovery
1st - 3rd September 2010
The Next Generation Drug Discovery Summit Europe is designed to bridge the growing technological gap between drug discovery and drug development.
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.